Sales made under the Pharmaceutical Benefits Scheme and the Repatriation Benefits Scheme account for about 50 per cent of the Australian market for pharmaceuticals. Approximately one-quarter of the companies supply about 90 per centanbsp;...
|Title||:||Another Side to the Drug Debate--a Medicated Society?|
|Author||:||Australia. Parliament. Senate. Standing Committee on Social Welfare|